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1  Introduction
Curcuminoids are natural phenylpropanoids from the
plant Curcuma longa Linn. Its rhizome contains a mixture
of curcuminoids, with curcumin, demethoxycurcumin,
and bisdemethoxycurcumin present in higher amounts.
These compounds present in turmeric have long been
used in traditional Asian food and medicine. Their thera-
peutic properties include anti-cancer, anti-inflammatory,
anti-oxidant, anti-Alzeimer’s, anti-HIV, and anti-Parkin-
son [1–4]. Despite their numerous benefits to human
health, curcuminoids have poor bioavailability and their
natural abundance is low, thus making their heterologous
biosynthetic production very interesting.
Recently, curcuminoids were found to be synthesized
by type III polyketide synthases (PKSs) and additional
enzymes from the phenylpropanoid pathway in plants [5].
Katsuyama et al. [6] were the first to produce curcumi-
noids using an artificial pathway in E. coli. They used
phenylalanine ammonia lyase (PAL) from Rhodotorula
rubra with tyrosine ammonia lyase (TAL) activity to con-
vert the amino acids phenylalanine and tyrosine directly
to cinnamic acid and p-coumaric acid. 4-coumarate-CoA
ligase (4CL) from Lithospermum erythrorhizon was used
to convert cinnamic acid and p-coumaric acid to cin-
namoyl-CoA and p-coumaroyl-CoA, respectively, and
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then to curcuminoids by curcuminoid synthase (CUS)
from Oryza sativa. Acetyl-CoA carboxylase (ACC) from
Corynebacterium glutamicum was also overexpressed to
increase the intracellular pool of malonyl-CoA. The sup-
plementation of amino acids to the medium led to the
 production of bisdemethoxycurcumin and other two cur-
cuminoids, cinnamoyl-p-coumaroylmethane, and dicin-
namoylmethane. The direct supplementation of car-
boxylic acids, as ferulic acid for instance, led to other cur-
cuminoids including curcumin and demethoxycurcumin
[6]. By adding two different unnatural carboxylic acids
simultaneously (analogs of p-coumaric acid), Katsuyama
and coworkers also produced unnatural curcuminoids [7].
Moreover, Wang et al. [8] produced the curcuminoid
dicinnamoylmethane by using PALs from Trifolium
pratense, 4CL1 from Arabidopsis thaliana and CUS from
O. sativa. After CUS was discovered, Katsuyama et al. [9]
reported that in the C. longa plant, the PKSs used to pro-
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Figure 1. Proposed curcuminoid biosynthetic pathway in E. coli and the reactions catalyzed by the enzymes in this study. TAL, tyrosine ammonia lyase;
C3H, 4-coumarate 3-hydroxylase; 4CL, 4-coumarate-CoA ligase; CCoAOMT, caffeoyl-CoA 3-O-methyltransferase; DCS, diketide-CoA synthase; CURS1,
 curcumin synthase; CUS, curcuminoid synthase.
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duce curcuminoids were diketide-CoA synthase (DCS)
and curcumin synthase (CURS1). They also identified oth-
er CURS enzymes (CURS2 and CURS3) with different sub-
strate specificities [10]. It is important to bear in mind that
CUS catalyzes both steps that are catalyzed separately by
DCS and CURS [9] (Fig. 1).
In this work, we describe curcuminoid production in
E. coli using an artificial pathway (Fig. 1). We tested 4CL1
from A. thaliana (At4CL1) and different PKSs for curcum-
inoid production (CUS, DCS, and CURS1). Curcumin,
demethoxycurcumin, and bisdemethoxycurcumin were
produced by adding ferulic acid and/or p-coumaric acid
as precursors. To produce curcuminoids, including cur-
cumin, from the amino acid tyrosine, caffeic acid had to
be produced as an intermediate in the pathway. TAL from
R. glutinis and 4-coumarate 3-hydroxylase (C3H) from
S. espanaensis were selected to produce caffeic acid
based on the results obtained in our previous work 
(J. Rodrigues et al., submitted). Caffeoyl-CoA was con-
verted to feruloyl-CoA by CCoAOMT from Medicago sati-
va. This alternative pathway through caffeic acid allowed,
for the first time, the production of curcumin, the most
studied curcuminoid for therapeutic purposes and con-
sidered in many studies as the most potent and active 
[3, 4], from the amino acid tyrosine, thus representing an
advance in the heterologous production of curcumin by 
E. coli.
2  Materials and methods
2.1  Bacterial strains, plasmids, and chemicals
E. coli NZY5α competent cells (NZYTech, Lisbon, Portu-
gal) were used for molecular cloning and vector propaga-
tion and E. coli K-12 MG1655(DE3) [11] was used as the
host for the expression of genes under T7 promoter con-
trol. The characteristics of all the strains and plasmids
used in this study are described in Table 1. TAL, C3H,
DCS, CURS1, CUS, and CCoAOMT genes were codon-
optimized for E. coli, synthesized and cloned in the plas-
mid vector pUC57 by GenScript (Piscataway, NJ, USA) or
NZYTech (Lisbon, Portugal). The DNA sequences of the
codon-optimized genes are provided in Supporting Infor-
mation, Table S1. pAC_At4CL1 was purchased from
Addgene (Cambridge, MA, USA).
Restriction and ligation enzymes (NEB, Ipswich, MA,
USA), KAPA HiFi DNA polymerase enzyme (Kapa Biosys-
tems, Wilmington, MA, USA), NucleoSpin® Plasmid
Miniprep Kit (Macherey-Nagel, Düren, Germany) and
DNA Clean and Concentrator and Gel DNA Recovery Kits
(Zymo Research, Orange, CA, USA) were used according
to the instructions provided by the manufacturers.
L-tyrosine, p-coumaric, caffeic acid, demethoxycur-
cumin, and bisdemethoxycurcumin were purchased from
Sigma–Aldrich (Steinheim, Germany), ferulic acid from
Acros (Geel, Belgium), curcumin from Fisher Scientific
(Loughborough, UK), isopropyl β-D-thiogalactopyranoside
(IPTG) and Luria-Bertani (LB) medium from NZYTech
(Lisbon, Portugal) and anhydrotetracycline (aTc) from
Acros. Glucose (Acros), Na2HPO4 (Scharlau, Sentmenat,
Spain), MgSO4, KH2PO4 (Riel-deHaën, Seelze, Germany),
NH4Cl, NaCl, CaCO3 (Panreac, Barcelona, Spain), and
 thiamine (Fisher Scientific, Loughborough, UK) were
used to prepare the M9 modified salt medium. The fol-
lowing mineral traces and vitamins were supplemented
to the M9 medium: FeCl3, ZnCl2, CoCl2, CuCl2, nicotinic
acid (Riedel-deHaën), NaMoO4, H2BO3, pyridoxine,
biotin, folic acid (Merck), riboflavin, and pantothenic acid
(Sigma–Aldrich). Ampicillin (Applichem, Darmstadt, Ger-
many), chloramphenicol, kanamycin (NZYTech), and
spectinomycin (Panreac) were used when necessary.
2.2  Construction of plasmids
The genes encoding CUS, CURS1, DCS, CCoAOMT, TAL,
and C3H were expressed in E. coli cells using the
 pETDuet-1, pCDFDuet-1, pRSFDuet-1 and pKVS45 vec-
tors (Table 1) and were cloned using the appropriate
restriction enzymes (Supporting information, Table S2).
All constructed plasmids herein described were veri-
fied by colony PCR or digestion and confirmed by
sequencing (Macrogen, Amsterdam, The Netherlands).
2.3  Curcuminoid production
E. coli cells for gene cloning, plasmid propagation, and
inoculum preparation were grown in LB medium at 37°C
and 200 rpm.
For the production of curcuminoids, the cultures were
grown at 37°C in LB (50  mL) to an optical density at 
600 nm of 0.3–0.4. IPTG and/or aTc were added (final con-
centration of 1 mM and 100 ng/mL, respectively) to induce
protein expression. The culture was then incubated for
5 h at 26°C. Next, the cells were harvested by centrifuga-
tion, suspended, and incubated at 26°C for 63 h in modi-
fied M9 minimal salt medium (50  mL) containing (per
liter): glucose (40 g), Na2HPO4 (6 g), KH2PO4 (3 g), NH4Cl
(1 g), NaCl (0.5 g), CaCl2 (17 mg), MgSO4 (58 mg), thiamine
(340 mg), and CaCO3 (5 g) (to control the pH). Trace ele-
ments [FeCl3 (54 mg), ZnCl2 (4 mg), CoCl2 (4 mg), NaMoO4
(4  mg), CuCl2 (2  mg), and H2BO3 (1  mg)] and vitamins
[riboflavin (0.84 mg), folic acid (0.084 mg), nicotinic acid
(12.2 mg), pyridoxine (2.8 mg), biotin (0.12 mg), and pan-
tothenic acid (10.8 mg)] were also supplemented to the
M9 medium. Depending on the plasmid(s) present in the
strain, ampicillin (100 μg/mL), spectinomycin (100 μg/mL),
chloramphenicol (30 μg/mL), and/or kanamycin (50 μg/mL)
were added. aTc and IPTG were added at the same time.
Substrates were added at time 0 of induction in M9 medi-
um (unless otherwise stated): tyrosine (3 mM), p-coumar-
ic acid (2  mM), caffeic acid (1  mM) and ferulic acid
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(2 mM). All the experiments were performed in triplicate
unless otherwise specified.
2.4  Curcuminoid extraction
For posterior analysis, 2 mL of culture broth were taken at
several points during the fermentation and adjusted to 
pH 3.0 with HCl (6 M). Then, the curcuminoids present in
the samples were extracted with an equal volume of eth-
yl acetate. The extraction procedure was performed more
than once for the cases in which the presence of curcum-
inoids inside the cells after the first extraction was still
visible to the naked eye (yellow coloration). The extracts
were concentrated by solvent evaporation in a fume hood,
suspended in at least 200 μL of acetonitrile and then sub-
jected to product analysis by high-performance liquid
chromatography (HPLC).
2.5  HPLC analysis of hydroxycinnamic acids 
and curcuminoids
HPLC analysis was used to quantify p-coumaric acid, caf-
feic acid, ferulic acid, curcumin, demethoxycurcumin,
and bisdemethoxycurcumin using a system from Jasco
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Table 1. Bacterial strains and plasmids used in this study
Strains Relevant Genotype Source
E. coli NZY5a fhuA2Δ(argF-lacZ)U169 phoA glnV44 Φ80 NZYTech
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17
E. coli K-12 MG1655 DE3 F- λ- ilvG- rfb-50 rph-1 λ(DE3) [11]
Plasmids Construct Source
pETDuet-1 ColE1(pBR322) ori, lacI, double T7lac, AmpR Novagen
pCDFDuet-1 CloDF13 ori, lacI, double T7lac, StrepR Novagen
pRSFDuet-1 RSF ori, lacI, double T7lac, KanR Novagen
pKVS45 p15A ori, tetR, Ptet, Amp
R [24]
pUC57_CCoAOMT pUC57 carrying codon-optimized CCoAOMT from M. sativa GenScript
pUC57_CUS pUC57 carrying codon-optimized CUS from O. sativa NZYTech
pUC57_DCS pUC57 carrying codon-optimized DCS from C. longa NZYTech
pUC57_CURS1 pUC57 carrying codon-optimized CURS1 from C. longa NZYTech
pAC_At4CL1 pAC carrying not codon-optimized 4CL1 from A. thaliana Addgene (35947)
pETDuet_TAL pETduet-1 carrying codon-optimized TAL from R. glutinis unpublished data
pETDuet_C3H pETduet-1 carrying codon-optimized C3H from S. espanaensis unpublished data
pETDuet_TAL_C3H pETduet-1 carrying codon-optimized TAL from R. glutinis and C3H from unpublished data
S. espanaensis
pKVS45_C3H pKVS45 carrying codon-optimized C3H from S. espanaensis unpublished data
pCDFDuet_TAL pCDFDuet-1 carrying codon-optimized TAL from R. glutinis unpublished data
pRSFDuet_CUS pRSFDuet-1 carrying codon-optimized CUS from O. sativa this study
pRSFDuet_CURS1 pRSFDuet-1 carrying codon-optimized CURS1 from C. longa this study
pCDFDuet_DCS pCDFDuet-1 carrying codon-optimized DCS from C. longa this study
pRSFDuet_CCoAOMT pRSFDuet-1 carrying codon-optimized CCoAOMT from M. sativa this study
pRSFDuet_At4CL1_CUS pRSFDuet_At4CL1 carrying codon-optimized CUS from O. sativa this study
pCDFDuet_DCS_CCoAOMT pCDFDuet_DCS carrying codon-optimized CCoAOMT from M. sativa this study
pRSFDuet_CURS1_CCoAOMT pRSFDuet_CURS carrying codon-optimized CCoAOMT from M. sativa this study
pCDFDuet_DCS_TAL pCDFDuet_DCS carrying codon-optimized TAL from R. glutinis this study
pCDFDuet_DCS_At4CL1 pCDFDuet_DCS carrying 4CL1 from A. thaliana this study
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 5
(Easton, MD, USA) (PU-2080 Plus Pump unit, LG-2080-02
Ternary Gradient unit, a DG-2080-53 3-Line Degasser
unit, a UV-2075 Plus Intelligent UV/VIS Detector unit, and
AS-2057 Plus Intelligent Sampler unit) and a Grace All-
tech Platinum EPS C18 column (3 μm, 150 mm × 4.6 mm)
(Grace, Columbia, MD, USA). Mobile phases A and B were
composed of water (0.1% trifluoroacetic acid) and ace-
tonitrile, respectively. For the hydroxycinnamic acids
quantification, the following gradient was used at a con-
stant flow rate (1  mL/min): 10–20% acetonitrile (mobile
phase B) for 16 min. Quantification was based on the peak
areas obtained at 310 nm for p-coumaric acid, caffeic acid
and ferulic acid. The retention times of p-coumaric acid,
caffeic acid and ferulic acid were 8.0, 11.8, and 13.8 min,
respectively. For the curcuminoid quantification, a gradi-
ent of 40–43% acetonitrile (mobile phase B) for 15 min and
43% acetonitrile for an additional 5  min was used. The
curcuminoids were detected at 425 nm and the retention
times of bisdemethoxycurcumin, demethoxycurcumin
and curcumin were 12.4, 13.5, and 14.5 min, respectively.
2.6  Protein analysis 
(CUS, CURS1, DCS, and CCoAOMT)
E. coli K-12 MG1655(DE3) cells harboring pRSFDuet_CUS,
pRSFDuet_CURS1, pRSFDuet_DCS and pRSFDuet_
CCoAOMT were grown in LB at 37°C to an optical densi-
ty at 600 nm of 0.6. IPTG was added (at a final concentra-
tion of 1 mM) to induce protein expression, and the cul-
ture was incubated for 5 h. Samples (10 mL culture medi-
um) were taken at time 0 and 5 h of induction. Samples
were centrifuged and the cells were suspended in phos-
phate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl,
10 mM Na2PO4, 1.8 mM KH2PO4, pH 7.4) and disrupted by
sonication on ice for 3 min. After centrifugation, the pro-
tein concentration from the resulting supernatant was
determined using Protein Assay Dye Reagent Concen-
trate (BioRad, Hercules, CA, USA) and bovine gamma
globulin (BSA) (NEB) as a standard. The expression levels
of the enzymes were examined using sodium dodecyl sul-
fate polyacrylamide gel electrophoretic (SDS–PAGE)
analysis. Fifteen to 20 μg of total protein were loaded in
4–20% Mini-PROTEAN® TGX™ Precast Gels (BioRad).
The protein marker used was Precision Plus Protein™
Unstained (BioRad) and/or ColorPlus™ Prestained Protein
Ladder Broad Range (NEB). For gel staining, Bio-Safe
Coomassie Stain (BioRad) was used.
3  Results
3.1  The 4-coumarate-CoA ligase (4CL) limiting step
4CL enzymes convert the hydroxycinnamic acids 
(p-coumaric acid, caffeic acid, and ferulic acid) to their
corresponding CoA esters (p-coumaroyl-CoA, caffeoyl-
CoA, and feruloyl-CoA) (Fig. 1) with different substrate
preferences and specificities. We studied three different
4CL enzymes (LeAt4CL1, At4CL2, and At4CL1) and only
At4CL1 was found to be functionally expressed. Recently,
this enzyme was successfully used in the production of
curcuminoids [8] and in stilbene and flavonoid biosynthe-
sis [12, 13]. In the current work, this enzyme was tested in
vivo with CUS and CURS1/DCS. Since the results
obtained regarding the production of curcuminoids were
positive, all the further optimization tests were performed
using this 4CL enzyme.
3.2  Very low production of curcuminoids 
using CUS from O. sativa 
Codon-optimized CUS was cloned in pRSFDuet-1 and its
expression was confirmed on a protein gel (44.3  kDa)
(Supporting information, Fig. S1). After that, CUS was
tested in E. coli with At4CL1 (pRSFDuet_CUS  + 
pAC_At4CL1) (Fig. 2). These enzymes produced bis -
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Figure 2. Curcuminoid production from
p-coumaric acid and ferulic acid using 
4-coumarate-CoA ligase (4CL1) from 
A. thaliana and curcuminoid synthase
(CUS) from O. sativa. Bisdemethoxycur-
cumin was also produced from tyrosine
using TAL from R. glutinis. Error bars are
standard deviations from triplicate
experiments.
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demetho xycurcumin and curcumin when p-coumaric
acid and ferulic acid, respectively, were added to the cul-
ture medium. Curcumin was produced in higher amount
(6.7 μM) than bisdemethoxycurcumin (0.9 μM).
Additionally, we found that the production of curcum-
inoids at 24 h is lower compared to 63 h which is in agree-
ment with the results reported by Katsuyama et al. [6].
This difference is significant (4.5 times lower) when cur-
cumin is produced compared to bisdemethoxycurcumin
production. Also, a yellow color of the culture medium,
due to the increase of curcuminoids inside the cells, could
only be observed after 24 h. The production of curcumi-
noids, even at low concentrations (0.9 μM) could be easi-
ly detected after 63 h (Supporting information, Fig. S2A
and B) by the observation of some cells that adhered to the
walls of the shake flasks.
To improve curcuminoid production, p-coumaric acid
and ferulic acid were supplemented to the culture medi-
um in two steps: 1 mM at time 0 of induction and 1 mM
after 24 h of induction. However, the production decreased
up to around 8.6 times. Bisdemethoxycurcumin was also
produced from tyrosine using TAL from R. glutinis (cloned
in pCDFDuet_TAL), At4CL1 and CUS. The production
was very similar to that obtained in the experiment in
which p-coumaric acid was added in two steps, which
probably means that the production/concentration of 
p-coumaric acid in the first 24 h affects the production of
bisdemethoxycurcumin. The production of p-coumaric
acid at 63 h was around 1500 μM, thus suggesting that
the TAL enzyme was highly functional.
3.3  DCS and CURS1 from C. longa allowed high
production levels of curcumin
Codon-optimized DCS and CURS1 were cloned in
 pRSFDuet-1 and their protein expression was also con-
firmed on a protein gel (Supporting information, Fig. S1).
The protein expression of DCS and CURS1 (42.9 kDa) was
very high; hence in vivo production was further tested.
Figure 3A illustrates the curcumin production from 
ferulic acid using pAC_At4CL1, pCDFDuet_DCS, and
pRSFDuet_CURS1. The production with these enzymes
was very high, 187.9 μM (70 mg/L) after 63 h. Besides, the
culture medium showed a dark orange color (Supporting
information, Fig. S2D), thus suggesting the production of
curcuminoids.
The addition of substrate (ferulic acid) was also tested
at three different time points, namely 1 mM at time zero
of induction in M9 medium, 0.5 mM at 5 h and an addi-
tional 0.5 mM 24 h after induction. As previously observed
(Fig. 3A), curcuminoid production was also significantly
lower (5.5 times) with multiple additions compared to
adding all the ferulic acid at time zero of induction.
To understand if the amount of cells (OD600) at the time
of induction in LB influenced the production of curcumi-
noids, we induced the cultures at different OD600 values
(Fig. 3B). We found that, although the cells should be
induced early, induction should not be too early since it
can impose a metabolic burden on the host strain associ-
ated with protein overexpression. The addition of IPTG at
an OD600 of 0.4 yielded the highest production titer
(187.9 μM), thus suggesting that induction should be per-
formed at an OD600 of 0.3–0.4. Moreover, we tested the
production by inducing the cells in LB and then in M9 at
37°C instead of 26°C. As expected the production of cur-
cumin at 37°C was residual. Low temperatures, around
26–30°C, should be used for optimal enzyme synthesis
and curcuminoid production.
Additionally, the effect of adding p-coumaric acid as a
substrate, or a mixture of p-coumaric acid and ferulic acid
in the production of other curcuminoids was also evaluat-
ed (Fig. 3C). The amount of bisdemethoxycurcumin pro-
duced was very low (5.0  μM) compared to curcumin
(187.9 μM), albeit 5 times higher than that obtained when
CUS was used instead of DCS and CURS1. The addition
of both substrates enabled the production of bis-
demethoxycurcumin, demethoxycurcumin and curcum-
in. Curcumin was produced at the highest concentration
(0.6  μM), followed by demethoxycucumin, due to the
 preference of feruloy-CoA as a substrate, compared to 
p-coumaroyl-CoA.
Bisdemethoxycurcumin could also be produced from
tyrosine, although in very small amounts (Fig. 3D), that is
almost 10 times lower than when p-coumaric acid is
added. To improve the curcuminoid production we cloned
At4CL1 in pCDFDuet-1 with DCS, however the curcumin
production was extremely low (~0.1 μM) compared to that
obtained when At4CL1 was in pAC plasmid (187.9 μM).
3.4  Caffeic acid can be successfully used 
as a precursor or intermediate 
in the production of curcuminoids
CCoAOMT (~27.3 kDa) was successfully expressed in E.
coli (Supporting information, Fig. S3) and was used to pro-
duce curcumin from caffeic acid. At4CL1 showed some
specificity for caffeic acid and CCoAOMT was found to be
functional since curcumin was produced in vivo using
these enzymes (Fig. 4A). However, the curcumin concen-
tration obtained was low (0.1–3.9 μM) as compared with
the production from ferulic acid (187.9 μM). This lower
production is probably due to the At4CL1 specificity. The
enzyme shows a much higher preference for ferulic acid
than for p-coumaric acid and caffeic acid. However,
At4CL1 seems to have a higher preference for caffeic acid
than for p-coumaric acid since the production of curcum-
in from caffeic acid and bisdemethoxycurcumin from 
p-coumaric acid (Fig. 3C) was very similar although more
steps are required to obtain curcumin. We tested different
approaches to clone CCoAOMT. CCoAOMT cloned in
pRSFDuet_CURS1 leads to a significant production of
curcuminoids, while if cloned in pCDFDuet_DCS the pro-
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duction is residual. Consequently, the first approach was
chosen to attempt the production of curcuminoids from
tyrosine.
Curcuminoid production, including curcumin, was
obtained from p-coumaric acid and tyrosine by using
 caffeic acid as an intermediate (Fig. 4B and C). When
p-coumaric is used as a precursor, the production of cur-
cuminoids is higher than when using tyrosine. Indeed,
this was expected since, as the number of intermediates
increases, the production of curcuminoids decreases, due
to the loss of product in each step of the pathway. When
p-coumaric acid is used as a substrate, bisdemethoxy-
curcumin is the curcuminoid produced in higher concen-
trations (~0.5 μM), followed by demethoxycurcumin. This
occurs probably because, due to the high concentration 
of p-coumaric acid added, p-coumaroyl-CoA is present 
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Figure 3. Curcuminoid production using
4-coumarate-CoA ligase (4CL1) from 
A. thaliana and diketide-CoA synthase
(DCS) and curcumin synthase 1
(CURS1) from C. longa. Curcumin pro-
duction from ferulic acid (A). Effect of
IPTG induction at different OD600 values
and effect of induction temperature on
the production titers of curcumin using
ferulic acid as substrate (B). Curcumi-
noid production from p-coumaric acid
and a mixture of p-coumaric acid and
ferulic acid (C). Bisdemethoxycurcumin
production from tyrosine using tyrosine
ammonia lyase (TAL) from R. glutinis
and curcumin production from ferulic
acid using a different plasmid configura-
tion (D). Error bars are standard devia-
tions from triplicate experiments.
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in a higher concentration than feruloyl-CoA, thus being
more available to produce a higher concentration of
 bisdemethoxycurcumin and demethoxycurcumin. Also,
pKVS45_C3H enabled a higher concentration of caffeic
acid than pETDuet_C3H (Fig. 4C), as we have observed
previously (J. Rodrigues et al., submitted). Consequently,
a higher caffeic acid concentration (299.5 μM) allowed the
production of more curcumin (0.3 μM). When tyrosine is
used as substrate, the caffeic acid concentration obtained
is lower (79.9–174.4 μM), and the p-coumaric acid con-
centration produced is also lower (354.6–568.0 μM) than
that maintained when it is added as a precursor
(1392.6–1571.3 μM). Although p-coumaric is present in a
higher concentration than caffeic acid (Fig. 4C), At4CL1
seems to prefer caffeic acid over p-coumaric acid and
consequently, curcumin (0.1–0.2 μM) is produced in high-
er amounts than bisdemethoxycurcumin (0.03–0.07 μM).
The concentration of the asymmetric curcuminoid
(demethoxycurcumin) is higher than the concentration
obtained of the symmetric curcuminoids (curcumin and
bisdemethoxycurcumin). The system using TAL and C3H
in the same plasmid (pETDuet_TAL_C3H) works better
than cloning TAL in pCDFDuet_DCS. In the latter case,
low expression levels of TAL seems to be the cause, as
was found for CCoAOMT (Fig. 4A), since the p-coumaric
acid production was low (354.6 μM) and consequently the
caffeic acid production was also low (79.9 μM), thus lead-
ing to a lower production of curcuminoids.
4  Discussion
Since there is an increasing interest in curcumin and oth-
er curcuminoids due to their several recognized beneficial
effects, synthetic biology and metabolic engineering con-
stitute good approaches to improve their availability. The
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Figure 4. Curcumin production from
caffeic acid using caffeoyl-CoA 3-O-
methyltransferase (CCoAOMT) from 
M. sativa, 4-coumarate-CoA ligase
(4CL1) from A. thaliana and diketide-
CoA synthase (DCS) and curcumin syn-
thase 1 (CURS1) from C. longa (A). Cur-
cuminoid production from p-coumaric
acid and tyrosine using caffeic acid as 
an intermediate and using TAL from 
R. glutinis, 4-coumarate 3-hydroxylase
(C3H) from Saccharothrix espanaensis,
CCoAOMT, 4CL1, DCS, and CURS1. In
(B) bisdemethoxycurcumin, demethoxy-
curcumin, and curcumin production are
shown while in (C) p-coumaric acid and
caffeic acid production are reported.
Error bars are standard deviations from
triplicate experiments.
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discovery of CUS from O. sativa allowed the production of
curcuminoids in E. coli [6, 7] and in vitro [14], which rep-
resented an important step forward in the production of
curcuminoids using the above mentioned strategies. CUS
has the advantage of catalyzing the three steps that are
catalyzed by different PKSs (CURS and DCS) in C. longa:
(a) condensation of malonyl-CoA with feruloyl-CoA (or
other CoA ester) to produce diketide-CoA; (b) hydrolysis
of diketide-CoA to its corresponding β-keto acid; and 
(c) decarboxylative condensation of the β-keto acid to the
second molecule of feruloyl-CoA (Fig. 1). This enzyme
would make the production of curcuminoids from tyrosine
simpler by decreasing the number of enzymes needed for
the pathway to function. In this study, we used CUS to
produce the three main curcuminoids in C. longa: bis-
demethoxycurcumin, demethoxycurcumin and curcum-
in. However, the amount of curcuminoids produced with
CUS was lower than the expected. The low titers (0.9 μM
of bisdemethoxycurcumin and 6.7 μM of curcumin) may
be due to use of plant enzymes in the pathway, which
usually are poorly stable in prokaryotes even with codon-
optimization owing to the lack of specific protein folding
chaperones and post-translational modifications. Ferulic
acid and/or feruloyl-CoA seem to be the preferred sub-
strates since curcumin was produced in higher amount
than bisdemethoxycurcumin. However, At4CL1 was
reported to prefer p-coumaric acid to ferulic acid [15] and
Katsuyama et al. [14] also concluded by in vitro experi-
ments that CUS prefers p-coumaroyl-CoA as a substrate.
Therefore, the reason behind the higher curcumin pro-
duction in this study is not clear. However, in vivo exper-
iments by the same authors [6] revealed that the CUS
enzyme together with Le4CL produces very similar
amounts of bisdemethoxycurcumin and curcumin from 
p-coumaric acid and ferulic acid, respectively, although
the curcumin concentration obtained was slightly higher.
It cannot be concluded if the higher concentration of cur-
cumin obtained in vivo was due to Le4CL substrate speci-
ficity, since it is unknown.
DCS and CURS1 were also chosen to test the curcum-
inoid production due to the promising results previously
reported in vitro [9, 10, 16]. Although these two genes
were successfully expressed in E. coli and the enzymes
were used to produce several curcuminoids, including
curcumin, DCS and CURS1 were never tested in vivo.
CURS1 was named curcumin synthase due to its pro-
nounced preference for feruloyl-CoA [9]. Moreover, other
CURS were identified. CURS2 was also reported to prefer
feruloyl-CoA and CURS3 favored both feruloy-CoA and 
p-coumaroyl-CoA [10]. Since curcumin has been reported
to possess, in some systems, a higher therapeutic value
than the other curcuminoids [17], CURS1 was chosen as
it has the highest turnover rate towards feruloyl-CoA, as
well as the highest difference between the catalytic effi-
ciency towards feruloyl-CoA and p-coumaroyl-CoA [10].
The production of curcumin using CURS1 and DCS was
surprisingly higher than we expected (187.9 μM), espe-
cially taking into account the results obtained with CUS.
This is the first report that demonstrates that these two
enzymes can be used efficiently to produce curcuminoids
in E. coli and provide high production titers. A higher con-
centration (113  mg/L) was reported using Le4CL, CUS,
and ACC [6]. It is important to note that ACC can be very
important to obtain high curcuminoids titers, in particu-
lar if there is a limitation of malonyl-CoA in the cells. How-
ever, comparing the results from Katsuyama et al. [6] and
Wang et al. [8] we can conclude that a high production of
curcuminoids can also be obtained without ACC overex-
pression. Katsuyama et al. [6] when using R. rubra PAL,
Le4CL, CUS, and ACC, and adding phenylalanine or cin-
namic acid were able to obtain around 107  mg/L or
84  mg/L of dicinnamoylmethane, respectively; while
Wang et al. [8] by using T. pratense PAL, At4CL1, and
CUS, and adding phenylalanine obtained 360 mg/L of
dicinnamoylmethane – that is a dicinnamoylmethane
concentration 3.4 times higher without the need of using
overexpressed ACC to increase the malonyl-CoA pool in
E. coli. Even though Wang et al. [8] obtained high pro-
duction of dicinnamoylmethane and we were able to
achieve a high production of curcumin, the ACC require-
ments should be further evaluated to confirm if malonyl-
CoA is limiting the production of curcuminoids.
To improve curcuminoid production, the substrates
were supplemented to the culture medium in two steps.
This stepwise approach was tested due to the possible
toxicity of p-coumaric and ferulic acids to the cells [12,
18–22], and because we found that this strategy improved
the production of caffeic acid in our previous work (sub-
mitted). However, in the current study the two-step feed-
ing was shown to be counterproductive, that is the pro-
duction decreased which means that the slow process of
curcuminoid production requires all the substrate avail-
able at the beginning of the fermentation to achieve a
high production.
The previous report on the heterologous production of
curcumin involves the direct supplementation of ferulic
acid in the culture medium [6]. To our knowledge, this is
the first report on the production of curcumin from tyro-
sine through the production of caffeic acid as an interme-
diate. CCoAOMT from M. sativa was used to catalyze the
methylation of caffeoyl-CoA, its preferred substrate, to
feruloyl-CoA and it was chosen since it has already been
expressed in E. coli [23]. After At4CL1 converts caffeic
acid to caffeoyl-CoA, CCoAOMT converts caffeoyl-CoA to
feruloyl-CoA which DCS and CURS1 can convert to cur-
cumin. To date, the levels of production are not very high;
however these can be improved by balancing different
expression levels. Imbalances can lead to over- or under-
production of enzymes and accumulation of intermediate
metabolites which may result in suboptimal titers. 
CURS1 has a higher preference for feruloyl-CoA than for
p-coumaroyl-CoA. However, the DCS preference for 
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p-coumaric acid or ferulic acid is unknown, although it is
established that its affinity for malonyl-CoA is high [9].
At4CL1 was reported to have a high affinity for p-coumar-
ic acid, followed by caffeic acid and a very low specificity
for ferulic acid [15], which seems to be contradicted by
our results. All these issues make it difficult to control the
curcuminoid production ratios, and more information
about the catalytic properties of all the enzymes involved
in the curcuminoid biosynthetic pathway is required.
Although up to now the production of curcuminoids from
tyrosine is low (up to 0.6 μM) and the curcuminoid ratio
difficult to control, this alternative pathway successfully
led to the production of curcumin from tyrosine. Curcum-
in, the most studied curcuminoid for therapeutic purpos-
es and in many studies considered as the most potent and
active [3, 4], was only shown to be produced in E. coli
using ferulic acid. This represents a disadvantage when
the production cost of curcumin is relevant, but also for
the cases in which curcumin is used as a drug that needs
to be produced and delivered in situ. By producing cur-
cumin using tyrosine (endogenous amino acid) and using
(in the future) a tyrosine overproducing strain, the need to
add expensive precursors disappears and the production
process is also simplified. Although it is clear that the
pathway herein described, depending on the application,
has to be further refined and optimized this is the first step
towards the production of curcumin from an amino acid
in E. coli and it is also the first time that caffeic acid is
used as an intermediate to produce curcuminoids. There-
fore, this alternative pathway represents a significant
progress in the heterologous production of curcumin
using E. coli.
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